99 related articles for article (PubMed ID: 16075053)
1. A molecule's right to choose: how diabetogenic class II MHC products bind peptides.
Ploegh HL
J Clin Invest; 2005 Aug; 115(8):2077-9. PubMed ID: 16075053
[TBL] [Abstract][Full Text] [Related]
2. Natural peptides selected by diabetogenic DQ8 and murine I-A(g7) molecules show common sequence specificity.
Suri A; Walters JJ; Gross ML; Unanue ER
J Clin Invest; 2005 Aug; 115(8):2268-76. PubMed ID: 16075062
[TBL] [Abstract][Full Text] [Related]
3. Biochemical characterization of the human diabetes-associated HLA-DQ8 allelic product: similarity to the major histocompatibility complex class II I-A(g)7 protein of non-obese diabetic mice.
Reizis B; Altmann DM; Cohen IR
Eur J Immunol; 1997 Oct; 27(10):2478-83. PubMed ID: 9368599
[TBL] [Abstract][Full Text] [Related]
4. Determination of glutamic acid decarboxylase 65 peptides presented by the type I diabetes-associated HLA-DQ8 class II molecule identifies an immunogenic peptide motif.
Herman AE; Tisch RM; Patel SD; Parry SL; Olson J; Noble JA; Cope AP; Cox B; Congia M; McDevitt2 HO
J Immunol; 1999 Dec; 163(11):6275-82. PubMed ID: 10570321
[TBL] [Abstract][Full Text] [Related]
5. The murine diabetogenic class II histocompatibility molecule I-Ag7: structural and functional properties and specificity of peptide selection.
Suri A; Unanue ER
Adv Immunol; 2005; 88():235-65. PubMed ID: 16227092
[TBL] [Abstract][Full Text] [Related]
6. Binding of conserved islet peptides by human and murine MHC class II molecules associated with susceptibility to type I diabetes.
Yu B; Gauthier L; Hausmann DH; Wucherpfennig KW
Eur J Immunol; 2000 Sep; 30(9):2497-506. PubMed ID: 11009082
[TBL] [Abstract][Full Text] [Related]
7. Self-peptides that bind with low affinity to the diabetes-associated I-A(g7) molecule readily induce T cell tolerance in non-obese diabetic mice.
Ferlin WG; Mougneau E; Hugues S; Appel H; Jang MH; Cazareth J; Beaudoin L; Schricke C; Lehuen A; Wucherpfennig KW; Glaichenhaus N
Eur J Immunol; 2004 Oct; 34(10):2656-63. PubMed ID: 15368281
[TBL] [Abstract][Full Text] [Related]
8. HLA Class II molecules on haplotypes associated with type 1 diabetes exhibit similar patterns of binding affinities for coxsackievirus P2C peptides.
Ellis RJ; Varela-Calvino R; Tree TI; Peakman M
Immunology; 2005 Nov; 116(3):337-46. PubMed ID: 16236123
[TBL] [Abstract][Full Text] [Related]
9. Posttranslational modification of HLA-DQ binding islet autoantigens in type 1 diabetes.
van Lummel M; Duinkerken G; van Veelen PA; de Ru A; Cordfunke R; Zaldumbide A; Gomez-Touriño I; Arif S; Peakman M; Drijfhout JW; Roep BO
Diabetes; 2014 Jan; 63(1):237-47. PubMed ID: 24089515
[TBL] [Abstract][Full Text] [Related]
10. Promiscuous binding of proinsulin peptides to Type 1 diabetes-permissive and -protective HLA class II molecules.
Astill TP; Ellis RJ; Arif S; Tree TI; Peakman M
Diabetologia; 2003 Apr; 46(4):496-503. PubMed ID: 12684749
[TBL] [Abstract][Full Text] [Related]
11. Differences in self-peptide binding between T1D-related susceptible and protective DR4 subtypes.
Ge X; James EA; Reijonen H; Kwok WW
J Autoimmun; 2011 Mar; 36(2):155-60. PubMed ID: 21257290
[TBL] [Abstract][Full Text] [Related]
12. Prediction of HLA-DQ8beta cell peptidome using a computational program and its relationship to autoreactive T cells.
Chang KY; Unanue ER
Int Immunol; 2009 Jun; 21(6):705-13. PubMed ID: 19461125
[TBL] [Abstract][Full Text] [Related]
13. "Humanized" HLA transgenic NOD mice to identify pancreatic beta cell autoantigens of potential clinical relevance to type 1 diabetes.
Serreze DV; Marron MP; Dilorenzo TP
Ann N Y Acad Sci; 2007 Apr; 1103():103-11. PubMed ID: 17376821
[TBL] [Abstract][Full Text] [Related]
14. Modulatory role of DR4- to DQ8-restricted CD4 T-cell responses and type 1 diabetes susceptibility.
Ge X; Piganelli JD; Tse HM; Bertera S; Mathews CE; Trucco M; Wen L; Rudert WA
Diabetes; 2006 Dec; 55(12):3455-62. PubMed ID: 17130492
[TBL] [Abstract][Full Text] [Related]
15. Multispecific responses by T cells expanded by endogenous self-peptide/MHC complexes.
Cai G; Hafler DA
Eur J Immunol; 2007 Mar; 37(3):602-12. PubMed ID: 17304631
[TBL] [Abstract][Full Text] [Related]
16. Self-peptides bound to the type I diabetes associated class II MHC molecules HLA-DQ1 and HLA-DQ8.
Chicz RM; Lane WS; Robinson RA; Trucco M; Strominger JL; Gorga JC
Int Immunol; 1994 Nov; 6(11):1639-49. PubMed ID: 7865457
[TBL] [Abstract][Full Text] [Related]
17. Analysis of eluted peptides from type 1 diabetes-susceptible HLA class II molecules identified novel islet protein, heparin/heparan sulfate-interacting protein.
Nakanishi K; Komatsu Y; Kogawa N; Matsushita H
Biochem Biophys Res Commun; 2005 Apr; 329(1):356-61. PubMed ID: 15721314
[TBL] [Abstract][Full Text] [Related]
18. An insulin-like growth factor 2-derived self-antigen inducing a regulatory cytokine profile after presentation to peripheral blood mononuclear cells from DQ8+ type 1 diabetic adolescents: preliminary design of a thymus-based tolerogenic self-vaccination.
Geenen V; Louis C; Martens H
Ann N Y Acad Sci; 2004 Dec; 1037():59-64. PubMed ID: 15699493
[TBL] [Abstract][Full Text] [Related]
19. The P9 pocket of HLA-DQ2 (non-Aspbeta57) has no particular preference for negatively charged anchor residues found in other type 1 diabetes-predisposing non-Aspbeta57 MHC class II molecules.
Quarsten H; Paulsen G; Johansen BH; Thorpe CJ; Holm A; Buus S; Sollid LM
Int Immunol; 1998 Aug; 10(8):1229-36. PubMed ID: 9723710
[TBL] [Abstract][Full Text] [Related]
20. Activation and control of pathogenic T cells in OSP/claudin-11-induced EAE in SJL/J mice are dominated by their focused recognition of a single epitopic residue (OSP58M).
Kaushansky N; Eisenstein M; Oved JH; Ben-Nun A
Int Immunol; 2008 Nov; 20(11):1439-49. PubMed ID: 18801757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
